The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
In September 2009, the Indian Health Service joined the Drug Safety Oversight Board as a new member of the Board. The Board also has representatives from five other federal government agencies, the Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Department of Defense (DOD), National Institutes of Health (NIH), and Department of Veterans Affairs (VA).
IHS provides healthcare to 1.9 million of the estimated 3.3 million Native Americans from 562 federally recognized tribes; provides knowledge of the Indian healthcare system; and brings a wealth of patient care information, data, and experience to FDA's Drug Safety Oversight Board. The IHS plans to join the DoD, VA, and FDA drug risk communication sharing Memorandum of Understanding sometime in fall or winter 2009.
Please visit the Drug Safety Oversight Board website at: DSB
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@xxxxxxxxxxx.
For additional drug information, please visit the DDI Web page
For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
